Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
Med Leg J ; : 258172241236269, 2024 Jun 13.
Article in English | MEDLINE | ID: mdl-38872233

ABSTRACT

BACKGROUND: Increasing numbers of cyber attacks threaten us personally and professionally. Cyber crimes include obtaining sensitive information (medical or financial) but may extend to organising heinous crimes including murders and aggravated sexual assaults. A major vector of cyber crimes is brute force attacks on secured shell servers. AIM OF STUDY: This research highlights the prevalence of the intensity of brute force attacks on secured shell servers via quali-quantitative analysis of cyber attacks. METHODOLOGY: The brute force attacks were recorded over a period of 20 days with the help of logs taken from five dedicated servers installed in a production environment. RESULTS: There were a minimum of 6470 and maximum of 22,715 attacks on a server per day. The total number of attacks on all the servers during the study period was 1,065,920. The brute force attacks were mainly targeted at the service network accounts. CONCLUSION: Growth of the field of cyber forensics is the optimal solution to prevent the malicious use of internet services and the commissioning of crimes by this means.

2.
Curr Res Struct Biol ; 7: 100120, 2024.
Article in English | MEDLINE | ID: mdl-38205118

ABSTRACT

Coronavirus disease-2019 (COVID-19) has become a global pandemic, necessitating the development of new medicines. In this investigation, we identified potential natural flavonoids and compared their inhibitory activity against spike glycoprotein, which is a target of SARS-CoV-2 and SARS-CoV. The target site for the interaction of new inhibitors for the treatment of SARS-CoV-2 has 82% sequence identity and the remaining 18% dissimilarities in RBD S1-subunit, S2-subunit, and 2.5% others. Molecular docking was employed to analyse the various binding processes used by each ligand in a library of 85 natural flavonoids that act as anti-viral medications and FDA authorised treatments for COVID-19. In the binding pocket of the target active site, remdesivir has less binding interaction than pectolinarin, according to the docking analysis. Pectolinarin is a natural flavonoid isolated from Cirsiumsetidensas that has anti-cancer, vasorelaxant, anti-inflammatory, hepatoprotective, anti-diabetic, anti-microbial, and anti-oxidant properties. The S-glycoprotein RBD region (330-583) is inhibited by kaempferol, rhoifolin, and herbacetin, but the S2 subunit (686-1270) is inhibited by pectolinarin, morin, and remdesivir. MD simulation analysis of S-glycoprotein of SARS-CoV-2 with pectolinarin complex at 100ns based on high dock-score. Finally, ADMET analysis was used to validate the proposed compounds with the highest binding energy.

3.
Int J Bioinform Res Appl ; 10(3): 235-63, 2014.
Article in English | MEDLINE | ID: mdl-24794069

ABSTRACT

ß-lactam antibiotics are utilised to treat bacterial infection. ß-lactamase enzymes (EC 3.5.2.6) are produced by several bacteria and are responsible for their resistance to ß-lactam antibiotics like penicillin, cephamycins and carbapenems. New Delhi Metallo-ß-lactamase (NDM-1) is a gene that makes bacteria resistant to ß-lactam antibiotics. Preparing a compound against NDM-1 will require additional investment and development by drug manufacturers as the current antibiotics will not treat patients with NDM-1 resistance. NDM-1 of Kolkata showed convergent-type evolution with other NDM-1 producing strains. The modelled structure exhibited α-ß-α barrel-type domain along with Zn metallo-ß-lactamase N-terminal domain. Compounds belonging to cephalosporins (relatively resistant to ß-lactamase) and other antibiotics ceftaroline, ceftobiprole, piperacillin, penamecillin, azidocillin, cefonicid, tigecycline and colistin have exhibited better binding affinity with the modelled NDM-1.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Drug Design , Drug Evaluation, Preclinical/methods , Evolution, Molecular , Models, Chemical , beta-Lactamases/chemistry , beta-Lactamases/genetics , Binding Sites , Computer Simulation , Enzyme Inhibitors/chemical synthesis , beta-Lactamases/ultrastructure
4.
Br J Pharmacol ; 171(5): 1260-74, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24670148

ABSTRACT

BACKGROUND AND PURPOSE: The combination of paromomycin-miltefosine is a successful anti-leishmanial therapy in visceral leishmaniasis (VL). This encouraged us to study its effect on Toll-like receptor (TLR)-mediated immunomodulation of dendritic cells (DC), as DC maturation and activation is crucial for anti-leishmanial activity. EXPERIMENTAL APPROACH: In silico protein-ligand interaction and biophysical characterization of TLR9-drug interaction was performed. Interaction assays of HEK293 cells with different concentrations of miltefosine and/or paromomycin were performed, and NF-κB promoter activity measured. The role of TLR9 and MyD88 in paromomycin/miltefosine-induced maturation and activation of DCs was evaluated through RNA interference techniques. The effect of drugs on DCs was measured in terms of counter-regulatory production of IL-12 over IL-10, and characterized by chromatin immunoprecipitation assay at the molecular level. KEY RESULTS: Computational and biophysical studies revealed that paromomycin/miltefosine interact with TLR9. Both drugs, as a monotherapy/combination, induced TLR9-dependent NF-κB promoter activity through MyD88. Moreover, the drug combination induced TLR9/MyD88-dependent functional maturation of DCs, evident as an up-regulation of co-stimulatory markers, enhanced antigen presentation by increasing MHC II expression, and increased stimulation of naive T-cells to produce IFN-γ. Both drugs, by modifying histone H3 at the promoter level, increased the release of IL-12, but down-regulated IL-10 in a TLR9-dependent manner. CONCLUSIONS AND IMPLICATIONS: These results provide the first evidence that the combination of paromomycin-miltefosine critically modifies the maturation, activation and development of host DCs through a mechanism dependent on TLR9 and MyD88. This has implications for evaluating the success of other combination anti-leishmanial therapies that act by targeting host DCs.


Subject(s)
Antiprotozoal Agents/pharmacology , Dendritic Cells/drug effects , Leishmaniasis, Visceral/metabolism , Myeloid Differentiation Factor 88/metabolism , Paromomycin/pharmacology , Phosphorylcholine/analogs & derivatives , Toll-Like Receptor 9/metabolism , Adult , Antiprotozoal Agents/therapeutic use , Cells, Cultured , Dendritic Cells/cytology , Dendritic Cells/microbiology , Drug Combinations , Female , HEK293 Cells , Humans , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-12/genetics , Interleukin-12/metabolism , Leishmaniasis, Visceral/drug therapy , Male , Paromomycin/therapeutic use , Phosphorylcholine/pharmacology , Phosphorylcholine/therapeutic use
5.
Asian Pac J Cancer Prev ; 14(12): 7473-82, 2013.
Article in English | MEDLINE | ID: mdl-24460321

ABSTRACT

The G-protein coupled receptor 87 (GPR87) is a recently discovered orphan GPCR which means that the search of their endogenous ligands has been a novel challenge. GPR87 has been shown to be overexpressed in squamous cell carcinomas (SCCs) or adenocarcinomas in lungs and bladder. The 3D structure of GPR87 was here modeled using two templates (2VT4 and 2ZIY) by a threading method. Functional assignment of GPR87 by SVM revealed that along with transporter activity, various novel functions were predicted. The 3D structure was further validated by comparison with structural features of the templates through Verify-3D, ProSA and ERRAT for determining correct stereochemical parameters. The resulting model was evaluated by Ramachandran plot and good 3D structure compatibility was evidenced by DOPE score. Molecular dynamics simulation and solvation of protein were studied through explicit spherical boundaries with a harmonic restraint membrane water system. A DRY-motif (Asp-Arg-Tyr sequence) was found at the end of transmembrane helix3, where GPCR binds and thus activation of signals is transduced. In a search for better inhibitors of GPR87, in silico modification of some substrate ligands was carried out to form polar interactions with Arg115 and Lys296. Thus, this study provides early insights into the structure of a major drug target for SCCs.


Subject(s)
Computational Biology/methods , Drug Design , Molecular Dynamics Simulation , Receptors, Lysophosphatidic Acid/chemistry , Amino Acid Sequence , Humans , Molecular Sequence Data , Phylogeny , Protein Structure, Secondary , Receptors, Lysophosphatidic Acid/metabolism , Sequence Homology, Amino Acid , Software
6.
J Biomol Struct Dyn ; 31(3): 258-75, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22830998

ABSTRACT

Drug resistance acquired by Leishmania donovani (Ldv) is a major problem in the treatment and control of visceral leishmaniasis (VL). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a major glycolytic enzyme has been targeted as is found in other protozoan which cause diseases like sleeping sickness. GAPDH gene of Ldv (AG83 strain) was amplified, sequenced, and modeled on the basis of crystal structure of Leishmania mexicana. The model of the Ldv GAPDH exhibited NAD-binding domain with Rossmann folding. Virtual screening of different experimentally proved compounds with the crystal and the modeled structures of GAPDH of Leishmania strains revealed diverse binding affinities of different compounds. Comparison of binding affinities (based on different programs) of compounds revealed that discovery studio v2.5 (Ligandfit) was able to predict the most hit compounds, the best hit compounds against GAPDH of Leishmania strains are hydrazine, vetrazine, and benzyl carbazate. It is predicted that patients suffering from both VL and cardiac disorders (atrial fibrillation) may benefit if they are treated with warfarin in conjunction with first-line antileishmanial therapies such as miltefosine and AmBisome.


Subject(s)
Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Leishmania donovani/enzymology , Sequence Analysis, Protein , Amino Acid Sequence , Binding Sites , DNA Primers/metabolism , Leishmania donovani/drug effects , Molecular Docking Simulation , Molecular Dynamics Simulation , Molecular Sequence Data , NAD/metabolism , Phylogeny , Protein Binding/drug effects , Protein Processing, Post-Translational/drug effects , Protein Subunits/chemistry , Protein Subunits/metabolism , RNA, Protozoan/isolation & purification , Reproducibility of Results , Thermodynamics , Triazoles/chemistry , Triazoles/pharmacology
7.
Integr Biol (Camb) ; 4(11): 1351-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23001143

ABSTRACT

UNLABELLED: There has been a revival of interest in Cysteine protease for Visceral Leishmaniasis (VL) attributed to massive outbreaks of leishmaniasis in the tropical region. The cysteine protease database (CPDB) was designed to find data related to cysteine protease (CP) of different species of Leishmania and Trypanosoma brucei in a single platform. This has reflected in substantial increase in the submission of Leishmania genome sequences to NCBI (National Center for Biotechnology Information) database. The CPDB database aims to provide a summary of data analysis, such as physiochemical and molecular properties, proteolytic cleavage sites, classification into functional families using SVMProt and other ExPASy tools. The main aim of this database is to provide different protein inhibitors of cysteine protease groups that were collected from literature and make available their 3-D structures through JMol with JAVA platform. These CP inhibitors are freely downloadable and also have added links for functional analyses of other proteins, which is helpful for users. All this information in CPDB, a single platform, will prove to be of great help for researchers who are involved in drug discovery and analysis of other physiochemical and molecular properties of the protein. AVAILABILITY: the database is available for free at.


Subject(s)
Cysteine Proteases/genetics , Databases, Chemical , Leishmania/enzymology , Leishmania/genetics , Animals , Cysteine Proteases/chemistry , Cysteine Proteases/classification , Cysteine Proteinase Inhibitors/chemistry , Cysteine Proteinase Inhibitors/pharmacology , Drug Discovery , Genes, Protozoan , Humans , Leishmania/drug effects , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/parasitology , Species Specificity , Systems Biology
8.
J Antimicrob Chemother ; 67(10): 2373-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22761329

ABSTRACT

OBJECTIVES: To evaluate the in vitro activity of antileishmanial drugs, paromomycin and miltefosine, to generate Th-1-biased immunomodulation in hosts against intracellular Leishmania donovani. METHODS: In silico protein-ligand interaction and in vitro drug-cell interaction assays were performed. Interaction assays of TLR4-deficient HEK293 cells and HEK293 cells engineered to express either TLR4 or TLR2 with different concentrations of miltefosine and/or paromomycin sulphate were performed for 48 h. Differentially transfected human peripheral blood monocyte-derived macrophages (PBMFs) were treated with the drugs, and nuclear factor (NF)-κB promoter activity was measured using a κB-luciferase reporter construct. PBMFs were infected with L. donovani. Cultures were incubated with miltefosine or paromomycin sulphate over different concentrations, as mono-treatment or combined. The in vitro antileishmanial effect of the drugs on macrophage-bound L. donovani amastigotes was measured in terms of parasite killing and production of tumour necrosis factor-α (TNF-α) and nitric oxide. RESULTS: Computational studies reveal that paromomycin and miltefosine interact with TLR4. Both drugs, as monotherapy or in combination, induce release of TNF-α and nitric oxide in a TLR4-dependent manner. Interestingly, the TLR4-dependent action of the drugs leads to NF-κB promoter activation through MyD88. In vitro, both the drugs kill macrophage-bound L. donovani by inducing release of TNF-α and nitric oxide in a TLR4-dependent manner. CONCLUSIONS: The in vitro activity of paromomycin and miltefosine against host cells is TLR4 dependent. This has implications for: (i) evaluation of in vitro activity of combinational antileishmanial therapy; (ii) the evaluation of drug susceptibility of clinical isolates; and (iii) the standardization of in vitro antileishmanial assays for determining toxicity in hosts.


Subject(s)
Antiprotozoal Agents/pharmacology , Immunologic Factors/pharmacology , Leishmania donovani/immunology , Paromomycin/pharmacology , Phosphorylcholine/analogs & derivatives , Toll-Like Receptor 4/agonists , Adolescent , Adult , Artificial Gene Fusion , Cell Survival , Cells, Cultured , Female , Gene Expression Profiling , Genes, Reporter , Humans , Luciferases/analysis , Luciferases/genetics , Macrophages/drug effects , Macrophages/immunology , Macrophages/parasitology , Male , NF-kappa B/biosynthesis , Nitric Oxide/metabolism , Phosphorylcholine/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Young Adult
9.
J Biomed Res ; 25(2): 100-10, 2011 Mar.
Article in English | MEDLINE | ID: mdl-23554678

ABSTRACT

EMR2 is an EGF-like module containing mucin-like hormone receptor-2 precursor, a G-protein coupled receptor (G-PCR). Mutation in EMR2 causes complicated disorders like polycystic kidney disease (PKD). The structure of EMR2 shows that the fifth domain is comprised of EGF-TM7 helices. Functional assignment of EMR2 by support vector machine (SVM) revealed that along with transporter activity, several novel functions are predicted. A twenty amino acid sequence "MGGRVFLVFLAFCVWLTLPG" acts as the signal peptide responsible for posttranslational transport. Eight amino acids are involved in N-glycosylation sites and two cleavage sites are Leu517 and Ser518 in EMR2. The residue Arg241 is responsible for interaction with glycosaminoglycan and chondroitin sulfate. On the basis of structure, function and ligand binding sites, competitive EMR2 inhibitors designed may decrease the rate of human diseases like Usher's syndrome, bilateral frontoparietal polymicrogyria and PKD.

10.
Am J Forensic Med Pathol ; 26(2): 170-3, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15894853

ABSTRACT

Acetylene is an inflammable gas commonly used for welding in small-scale industries. We present a case of a 34-year-old male welder who died following injuries sustained from explosion of an acetylene gas-welding cylinder. In this case report, we discuss the circumstances leading to the explosion of the welding cylinder, the autopsy findings, and a brief review of the literature on deaths resulting from blasts of acetylene cylinders.


Subject(s)
Accidents, Occupational , Acetylene , Blast Injuries/pathology , Explosions , Adult , Facial Injuries/pathology , Fractures, Bone/pathology , Humans , Male , Thoracic Injuries/pathology , Tooth Injuries/pathology , Trachea/injuries , Trachea/pathology , Welding
11.
Med Sci Law ; 44(2): 127-32, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15176625

ABSTRACT

A meticulous post-mortem review was undertaken in the department of forensic medicine at the Maulana Azad Medical College (MAMC) to find out trends in homicides during the period 1992-1996. Standard procedures for autopsies and a review of the inquest papers were carried out. Out of 3,886 medico-legal autopsies performed in the department during the said period, only 232 cases (5.9%) were homicidal deaths. The commonest age group of the victims was 21-30 years (38%). Males were victimized three times more often than females. The incidence of crime was slightly more at night than in the daytime, though evenly distributed during the winter and summer seasons. In our series, sharp weapon injuries were the most common type (34.9%) followed by blunt force injuries (15.9%). Defence wounds were present in 35 cases (15%). Violent rage/quarrel was the motive in 61 cases (29%).


Subject(s)
Homicide/statistics & numerical data , Adolescent , Adult , Aged , Autopsy , Child , Child, Preschool , Crime Victims , Female , Homicide/trends , Humans , India , Infant , Infant, Newborn , Male , Sex Factors , Survival Analysis , Time Factors , Violence/statistics & numerical data , Violence/trends , Wounds and Injuries
SELECTION OF CITATIONS
SEARCH DETAIL